Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Alexis Tabah, José Garnacho‐Montero, Matteo Bassetti et al.|Intensive Care Medicine|2019Cited by 185
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean‐François Timsit, Jean‐Ralph Zahar et al.|Clinical Infectious Diseases|2019Cited by 49
Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)Andrew F. Shorr, for the RESPOND Investigators, Bruno François et al.|Critical Care|2010Cited by 16